These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 19109317

  • 1. Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis.
    Salvarani C, Della Bella C, Cimino L, Macchioni P, Formisano D, Bajocchi G, Pipitone N, Catanoso MG, Restuccia G, Ghinoi A, Boiardi L.
    Rheumatology (Oxford); 2009 Mar; 48(3):250-3. PubMed ID: 19109317
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis.
    Salvarani C, Cimino L, Macchioni P, Consonni D, Cantini F, Bajocchi G, Pipitone N, Catanoso MG, Boiardi L.
    Arthritis Rheum; 2005 Apr 15; 53(2):293-7. PubMed ID: 15818722
    [Abstract] [Full Text] [Related]

  • 3. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis.
    Salvarani C, Casali B, Farnetti E, Pipitone N, Formisano D, Nicoli D, Macchioni P, Cimino L, Bajocchi G, Grazia Catanoso M, Restuccia G, Ghinoi A, Boiardi L.
    Arthritis Rheum; 2007 Oct 15; 56(10):3502-8. PubMed ID: 17907177
    [Abstract] [Full Text] [Related]

  • 4. High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.
    Berger CT, Wolbers M, Meyer P, Daikeler T, Hess C.
    Rheumatology (Oxford); 2009 Mar 15; 48(3):258-61. PubMed ID: 19129348
    [Abstract] [Full Text] [Related]

  • 5. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis.
    Cid MC, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, López-Soto A, Vilaseca J, Urbano-Márquez A, Grau JM.
    Arthritis Rheum; 1998 Jan 15; 41(1):26-32. PubMed ID: 9433866
    [Abstract] [Full Text] [Related]

  • 6. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
    Lee MS, Smith SD, Galor A, Hoffman GS.
    Arthritis Rheum; 2006 Oct 15; 54(10):3306-9. PubMed ID: 17009265
    [Abstract] [Full Text] [Related]

  • 7. Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
    Corrado E, Rizzo M, Muratori I, Coppola G, Novo S.
    Menopause; 2008 Oct 15; 15(2):240-7. PubMed ID: 17917609
    [Abstract] [Full Text] [Related]

  • 8. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.
    Lopez-Diaz MJ, Llorca J, Gonzalez-Juanatey C, Peña-Sagredo JL, Martin J, Gonzalez-Gay MA.
    Semin Arthritis Rheum; 2008 Oct 15; 38(2):116-23. PubMed ID: 18221984
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for severe cranial ischaemic events in patients with giant cell arteritis.
    Grossman C, Barshack I, Koren-Morag N, Ben-Zvi I, Bornstein G.
    Clin Exp Rheumatol; 2017 Oct 15; 35 Suppl 103(1):88-93. PubMed ID: 28466802
    [Abstract] [Full Text] [Related]

  • 10. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
    Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M.
    Arthritis Rheum; 2004 Apr 15; 50(4):1332-7. PubMed ID: 15077317
    [Abstract] [Full Text] [Related]

  • 11. -463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis.
    Salvarani C, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni PL, Cimino L, Bajocchi GL, Catanoso MG, Pattacini L, Ghinoi A, Restuccia G, Boiardi L.
    Ann Rheum Dis; 2008 Apr 15; 67(4):485-8. PubMed ID: 17704068
    [Abstract] [Full Text] [Related]

  • 12. Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study.
    Gonzalez-Gay MA, Rubiera G, Piñeiro A, Garcia-Porrua C, Pego-Reigosa R, Gonzalez-Juanatey C, Sanchez-Andrade A, Llorca J.
    J Rheumatol; 2005 Mar 15; 32(3):502-6. PubMed ID: 15742443
    [Abstract] [Full Text] [Related]

  • 13. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course.
    Liozon E, Boutros-Toni F, Ly K, Loustaud-Ratti V, Soria P, Vidal E.
    J Rheumatol; 2003 Jun 15; 30(6):1272-6. PubMed ID: 12784402
    [Abstract] [Full Text] [Related]

  • 14. Comment on: Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis.
    Steichen O.
    Rheumatology (Oxford); 2009 Sep 15; 48(9):1180; author reply 1180. PubMed ID: 19589889
    [No Abstract] [Full Text] [Related]

  • 15. Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population.
    Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J.
    Arthritis Rheum; 2004 Aug 15; 51(4):652-5. PubMed ID: 15334440
    [Abstract] [Full Text] [Related]

  • 16. Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis.
    Muratore F, Boiardi L, Cavazza A, Aldigeri R, Pipitone N, Restuccia G, Bellafiore S, Cimino L, Salvarani C.
    J Autoimmun; 2016 May 15; 69():94-101. PubMed ID: 27009904
    [Abstract] [Full Text] [Related]

  • 17. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden.
    Uddhammar A, Eriksson AL, Nyström L, Stenling R, Rantapää-Dahlqvist S.
    J Rheumatol; 2002 Apr 15; 29(4):737-42. PubMed ID: 11950015
    [Abstract] [Full Text] [Related]

  • 18. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
    Nojima J, Masuda Y, Iwatani Y, Kuratsune H, Watanabe Y, Suehisa E, Takano T, Hidaka Y, Kanakura Y.
    Rheumatology (Oxford); 2008 May 15; 47(5):684-9. PubMed ID: 18375400
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
    Parikh M, Miller NR, Lee AG, Savino PJ, Vacarezza MN, Cornblath W, Eggenberger E, Antonio-Santos A, Golnik K, Kardon R, Wall M.
    Ophthalmology; 2006 Oct 15; 113(10):1842-5. PubMed ID: 16884778
    [Abstract] [Full Text] [Related]

  • 20. C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain.
    Palomino-Morales R, Vazquez-Rodriguez TR, Miranda-Filloy JA, Martin J, Gonzalez-Gay MA.
    J Rheumatol; 2009 Feb 15; 36(2):341-6. PubMed ID: 19040303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.